Expand NEUP Menu
NEUP MENU

NEUP Stock Summary and Trading Ideas (Neuphoria Therapeutics | NASDAQ:NEUP)

Charts for Today's Stock Price and Implied Volatility in Neuphoria Therapeutics

13-Mar-2026

Stock Price & Volume | Full Chart

Sentiment

Trading Statistics

Key Ratios

Neuphoria Therapeutics (NEUP) Frequently Asked Questions

What does Neuphoria Therapeutics do?

Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.

What symbol and exchange does Neuphoria Therapeutics shares trade?

Neuphoria Therapeutics trades on the NASDAQ stock market under the symbol NEUP.

What is Neuphoria Therapeutics stock price doing today?

As of March 13, 2026, NEUP stock price declined to $4.54 with 116,774 million shares trading.

What is Neuphoria Therapeutics's Beta?

NEUP has a beta of -0.25, meaning it tends to be less sensitive to market movements. NEUP has a correlation of 0.00 to the broad based SPY ETF.

How much is Neuphoria Therapeutics worth?

NEUP has a market cap of $24.47 million. This is considered a Sub-Micro Cap stock.

What are the top ETFs holding Neuphoria Therapeutics?

The top ETF exchange traded funds that NEUP belongs to (by Net Assets): PSIL, VTI, VXF.

Is Neuphoria Therapeutics (NEUP) a good investment?

NEUP has underperformed the market in the last year with a return of -6.2%, while SPY returned +21.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NEUP shares. However, NEUP has outperformed the market in the last 3 month and 2 week periods, returning +11.3% and +9.4%, while SPY returned -2.6% and -3.5%, respectively. This indicates NEUP has been having a stronger performance recently.

What are the support and resistance levels for Neuphoria Therapeutics (NEUP)?

NEUP support price is $4.52 and resistance is $4.94 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NEUP shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes